{
"description": "b.well created value set by Sr. Clinical Business Analyst for High Risk HPV Test.",
"compose": {
"include": [ {
"valueSet": [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.328" ]
}, {
"valueSet": [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.329" ]
}, {
"valueSet": [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.330" ]
}, {
"valueSet": [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.331" ]
} ]
},
"_filename": "ValueSet-2.16.840.1.113762.1.4.1235.332.json",
"package_name": "us.nlm.vsac",
"date": "2023-06-16T01:00:56-04:00",
"meta": {
"profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ],
"versionId": "6",
"lastUpdated": "2023-12-21T17:43:03.000-05:00"
},
"publisher": "B.well Connected Health Steward",
"jurisdiction": [ {
"coding": [ {
"code": "US",
"system": "urn:iso:std:iso:3166"
} ]
} ],
"purpose": "(Clinical Focus: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.),(Data Element Scope: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.),(Inclusion Criteria: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.),(Exclusion Criteria: This value set's intent is to define the clinical codes that constitute the Clinical Care Need with High Risk HPV Test and utilization in patients/users connected health.)",
"name": "HighRiskHPVTest_HD_Grouping",
"type": null,
"experimental": null,
"resourceType": "ValueSet",
"expansion": {
"total": 24,
"contains": [ {
"code": "21440-3",
"system": "http://loinc.org",
"display": "Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by Probe",
"version": "2.78"
}, {
"code": "30167-1",
"system": "http://loinc.org",
"display": "Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification",
"version": "2.78"
}, {
"code": "35904009",
"system": "http://snomed.info/sct",
"display": "Human papillomavirus deoxyribonucleic acid detection (procedure)",
"version": "http://snomed.info/sct/731000124108/version/20240901"
}, {
"code": "38372-9",
"system": "http://loinc.org",
"display": "Human papilloma virus 6+11+16+18+31+33+35+39+42+43+44+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification",
"version": "2.78"
}, {
"code": "441667007",
"system": "http://snomed.info/sct",
"display": "Abnormal cervical Papanicolaou smear with human papillomavirus deoxyribonucleic acid detected (finding)",
"version": "http://snomed.info/sct/731000124108/version/20240901"
}, {
"code": "448651000124104",
"system": "http://snomed.info/sct",
"display": "Microscopic examination of cervical Papanicolaou smear and Human papillomavirus deoxyribonucleic acid detection cotesting (procedure)",
"version": "http://snomed.info/sct/731000124108/version/20240901"
}, {
"code": "59263-4",
"system": "http://loinc.org",
"display": "Human papilloma virus 16 DNA [Presence] in Cervix by Probe with signal amplification",
"version": "2.78"
}, {
"code": "59264-2",
"system": "http://loinc.org",
"display": "Human papilloma virus 18 DNA [Presence] in Cervix by Probe with signal amplification",
"version": "2.78"
}, {
"code": "59420-0",
"system": "http://loinc.org",
"display": "Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by Probe with signal amplification",
"version": "2.78"
}, {
"code": "69002-4",
"system": "http://loinc.org",
"display": "Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection",
"version": "2.78"
}, {
"code": "71431-1",
"system": "http://loinc.org",
"display": "Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection",
"version": "2.78"
}, {
"code": "718591004",
"system": "http://snomed.info/sct",
"display": "High risk human papillomavirus detected by cytology (finding)",
"version": "http://snomed.info/sct/731000124108/version/20240901"
}, {
"code": "720005005",
"system": "http://snomed.info/sct",
"display": "Human papillomavirus deoxyribonucleic acid detected, high risk on cervical specimen (finding)",
"version": "http://snomed.info/sct/731000124108/version/20240901"
}, {
"code": "75694-0",
"system": "http://loinc.org",
"display": "Human papilloma virus 18+45 E6+E7 mRNA [Presence] in Cervix by NAA with probe detection",
"version": "2.78"
}, {
"code": "77379-6",
"system": "http://loinc.org",
"display": "Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Interpretation] in Cervix",
"version": "2.78"
}, {
"code": "77399-4",
"system": "http://loinc.org",
"display": "Human papilloma virus 16 DNA [Presence] in Cervix by NAA with probe detection",
"version": "2.78"
}, {
"code": "77400-0",
"system": "http://loinc.org",
"display": "Human papilloma virus 18 DNA [Presence] in Cervix by NAA with probe detection",
"version": "2.78"
}, {
"code": "82354-2",
"system": "http://loinc.org",
"display": "Human papilloma virus 16 and 18+45 E6+E7 mRNA [Identifier] in Cervix by NAA with probe detection",
"version": "2.78"
}, {
"code": "82456-5",
"system": "http://loinc.org",
"display": "Human papilloma virus 16 E6+E7 mRNA [Presence] in Cervix by NAA with probe detection",
"version": "2.78"
}, {
"code": "82675-0",
"system": "http://loinc.org",
"display": "Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection",
"version": "2.78"
}, {
"code": "87624",
"system": "http://www.ama-assn.org/go/cpt",
"display": "Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), high-risk types (eg, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68), pooled result",
"version": "2025"
}, {
"code": "87625",
"system": "http://www.ama-assn.org/go/cpt",
"display": "Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), types 16 and 18 only, includes type 45, if performed",
"version": "2025"
}, {
"code": "95539-3",
"system": "http://loinc.org",
"display": "Human papilloma virus 31 DNA [Presence] in Cervix by NAA with probe detection",
"version": "2.78"
}, {
"code": "G0476",
"system": "http://www.nlm.nih.gov/research/umls/hcpcs",
"display": "Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test",
"version": "2024"
} ],
"timestamp": "2024-12-10T08:50:39-05:00",
"identifier": "urn:uuid:3774f1a3-3176-4870-b816-4003a0ab4246"
},
"title": "High Risk HPV Test_HD_Grouping",
"package_version": "0.21.0",
"extension": [ {
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "B.well Connected Health Author"
}
}, {
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2024-07-02"
}, {
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2023-06-16"
} ],
"status": "active",
"id": "742f57ee-7a36-40d8-85bc-ebbb63090306",
"kind": null,
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.332",
"identifier": [ {
"value": "urn:oid:2.16.840.1.113762.1.4.1235.332",
"system": "urn:ietf:rfc:3986"
} ],
"version": "20230616"
}